New York City, Jan. 29, 2018 --
Are you struggling to lose those extra inches off your waist, hips, thighs, or buttocks? NYC plastic surgeon Dr. Sharon Giese is now offering InstaLipo™ – the latest non-surgical liposuction technique – to achieve up to 2 or more inches of fat reduction during your first treatment without the need for extensive recovery time!
The midsection and legs are among the most notorious problem areas for many patients trying to reduce unwanted fat and improve body contours. Even with consistent dieting and exercise, stubborn fat may remain around the waistline, hips, thighs, or buttocks. InstaLipo™ is clinically proven to shrink stubborn fat cells and tighten skin without any pain, surgery, or downtime!
“InstaLipo™ is the only FDA approved non-surgical device for immediate size reduction,” says Dr. Giese. “During FDA approved clinical trials using InstaLipo™, patients lost an average of 3.5 inches after a single 32 minute session.”
The method? Red light therapy, which delivers photonic energy to the target area(s), draining fat cells of their contents (mainly fatty acids and triglycerides). These fat cells then shrink in size as your body naturally processes these contents, leading to a slimmer-looking lower body. Unlike traditional liposuction, which physically removes fat cells from your body, InstaLipo™ simply reduces the size of your fat cells, eliminating the risk of bruising or swelling associated with past fat removal methods. An additional benefit of InstaLipo™ treatment is the stimulation of collagen and elastin fibers beneath the surface of your skin, which can improve skin texture for a firmer, more youthful-looking appearance.
During InstaLipo™ treatment, patients simply lie down and relax while the InstaLipo™ device is positioned above each target area for periods of approximately 8 minutes. Low-level photonic energy is delivered to unwanted fat cells, effectively shrinking them. There are no incisions or stitches necessary with InstaLipo™ and patients can typically resume their daily activities immediately following treatment.
“Patients usually see substantial results with 1 treatment,” says Dr. Giese. “Additional treatments scheduled 1 week apart may be recommended to help you achieve your desired results.” Dr. Giese recommends a proper diet and consistent exercise plan following treatment to help patients maintain their InstaLipo™ results.
Dr. Sharon Giese is a board certified NYC plastic surgeon performing a variety of different facial rejuvenation, body sculpting, and non-surgical treatments. Dr. Giese attended Vassar College before earning her medical degree at Northwestern Medical School. She received plastic surgery training at Stanford University and completed a fellowship in breast and cosmetic surgery at Georgetown University. Dr. Giese is a proud member of the American Society of Plastic Surgeons, the American Board of Plastic Surgery, and the American Society of Aesthetic Plastic Surgeons. She has appeared on numerous media outlets, including Good Morning America, The Early Show, The Today Show, and The Dr. Oz Show to discuss the latest trends in cosmetic surgery.
If you are interested in learning more about InstaLipo™ , you can contact Dr. Sharon Giese at (212) 421-3400 or by requesting an appointment online to schedule your plastic surgery consultation.
For additional information: Dr. Sharon Giese 114 East 61st Street New York, New York 10065 (212) 421-3400 https://www.sharongiesemd.com/


Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 



